![Le Le Zhang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Le Le Zhang
Fondateur chez
CUTIA THERAPEUTICS
Fortune : 5 M $ au 30/06/2026
Profil
Le Le Zhang is the founder of Cutia Therapeutics, founded in 2019, holding the title of Chief Executive Officer & Executive Director since 2022.
The current job is General Manager & Director at Cutia Therapeutics (Shanghai) Co., Ltd. Education history includes a graduate degree from Shanghai Institute of Pharmaceutical Industry in 2005 and an undergraduate degree from Shenyang Pharmaceutical University in 2000.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUTIA THERAPEUTICS 4,11 % | 03/11/2025 | 15 007 236 ( 4,11 % ) | 5 M $ | 30/06/2026 |
Postes actifs de Le Le Zhang
| Sociétés | Poste | Début |
|---|---|---|
| CUTIA THERAPEUTICS | Fondateur | 15/05/2019 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Directeur Général | - |
Formation de Le Le Zhang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Shanghai Institute of Pharmaceutical Industry
 Shanghai Institute of Pharmaceutical Industry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
 Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Health Technology |
Cutia Therapeutics
 Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
